10 U.S.C. § 101 — Statute Treatment

Statute treatment: 10 U.S.C. § 101

Ranked leading cases interpreting this statute, drawn from 538 citation events across 284 distinct cases.
538citations total
284distinct interpreting cases
89distinct courts
121citations in last 5y
1957–2026year range
Top 20 leading cases
#1 United States v. Ali (2012) armfor 79 own cites 6× in case
#2 United States v. Rodriguez (2009) armfor 23 own cites 8× in case
#3 Min v. Avila (1999) texapp 72 own cites 4× in case
#4 Willenbring v. Neurauter (1998) armfor 37 own cites 5× in case
#5 Holmes v. California National Guard (2001) calctapp 55 own cites 4× in case
#6 United States v. Smead (2009) armfor 50 own cites 4× in case
#7 Denis E. Dehne v. The United States (1992) cafc 196 own cites 2× in case
#8 In Re Sealed Case (2009) cadc 15 own cites 6× in case
#9 Ltc. Oliver Donovan Ulmet v. The United States (1987) cafc 25 own cites 4× in case
#10 Bowen v. United States (2001) uscfc 40 own cites 3× in case
#11 Gary Jackson v. Thomas Modly (2020) cadc 36 own cites 3× in case
#12 Archer Frey v. State of California State of California Military Department (1993) ca9 21 own cites 4× in case
#13 Dehne v. United States (1991) cc 72 own cites 2× in case
#14 Gary W. Bowen v. United States (2002) cafc 70 own cites 2× in case
#15 O'Farrell v. Dep't of Def. (2018) cafc 13 own cites 5× in case
#16 Ulmet v. United States (1989) cc 12 own cites 5× in case
#17 Willenbring v. United States (2009) ca4 12 own cites 5× in case
#18 Valore v. Islamic Republic of Iran (2010) dcd 251 own cites 1× in case
#19 Cronin v. United States (2014) cafc 8 own cites 6× in case
#20 Murphy v. Islamic Republic of Iran (2010) dcd 176 own cites 1× in case

Ranking method: leading_score = ln(1 + own_citation_count) × √(mentions_in_case) × flag_factor, where flag_factor = 1.0 green · 0.6 unknown · 0.5 neutral · 0.4 yellow · 0.3 procedural · 0 red. Red-flagged cases excluded — their interpretation has been undermined and shouldn't lead the list. Top 20 returned per statute. Open any case for full G Cite, trajectory, and per-circuit treatment.